PR

stumblios

A bit more than a month for unfurling. Then successful testing was PR'd 4 months after the last launch. Maybe unfurling takes longer since this is the biggest satellite ever. Maybe testing takes less time since they've done a few?

Prudent-Session985

Nah it's just that everything is made up.  Deportations this year are going to be just beneath the peak under Obama.  But read the news and it looks like something is massively different because they're picking people up in courthouses. We don't have two radically different parties.  It's mostly PR differences to slightly different underlying policy.

itsybitsyspida

Lol. Serve robotics is a piece of shit company. Bloated executive compensation that bleeds shareholders. Poor acquisitions and trying to overcompensate for their failures with irrelevant PR.

Traditional_Base1184

I buy weekly calls and puts depending on if I break my PR in the gym, stagnate, or go down. So far up this year and I was weaker today... Puts

Individual-Chair-945

Jim Cramer on *Mad Money* said GRRR isn’t well-known yet after a retired fund analyst named Richard called in live saying he likes it. That’s not bearish. That’s pre-crowd. Sub-$300M cap. Thin tape. PR at this size = absolute mayhem. This is the part where nothing happens… until one headline nukes the chart. Not advice. Position: long GRRR shares. I like pain.

RaZE___SoViEt

Premarket Watchlist : **$RENX** : Can be a sympathy play of **$AIRE**, had some nice volume today due to PR below. **RSI** of 28 2.5M float 8% shorted. Could be nothing, worth a watchlist for rebound. Real estate development services with PR today : https://finviz.com/news/259826/renx-enterprises-expands-sustainable-growing-media-initiative-utilizing-ara-partners-backed-microtec-technology **$AIRE** : Swing, if it brakes 0.705 Known runner: https://finviz.com/news/260441/realpha-nasdaq-aire-signs-definitive-agreement-to-acquire-instamortgage **$DVLT** : reentered at 0.85 again after 10% : 2 PRs today small movement: 1: Premarket: https://finviz.com/news/259579/datavault-ai-inc-announces-issuance-of-two-foundational-us-patents-advancing-blockchain-driven-content-licensing-and-tokenized-monetization 2: AfterHours : https://finviz.com/news/260313/datavault-ai-and-the-dream-bowl-announce-national-broadcast-partnership-for-dream-bowl-xiv-and-confirm-dream-bowl-2026-meme-coin-claim-process-for-dec-24-drop **$RVPH** : 5.1% institutional buy 13G today, PH3 update anytime: https://www.sec.gov/Archives/edgar/data/1742927/000149315225028783/xslSCHEDULE_13D_X01/primary_doc.xml 4/17/26 1$ calls at 0.20 lotto **$WOK** : small China play **$BITF** , **$ASST** , **$GNS** : Rising mentions of Bitcoin on socials, trump buying: https://bitbo.io/news/trump-media-bitcoin-holdings/

artynonymous

Hold for sure, buy if you want more money imo. There's nothing for sure (announced) fueling this, but could be so many things. Reckless speculation says PR about phase 3 imminent

OsamaBagHolding

"They are not a vanity project There are no gimmicks This is not for PR or for Wallstreet We built a truck so people can use it in their daily lives" Ford CEO about the now cancelled Lighting. I'm pro electric vehicles, but damn this is hilarious in retro spec

confido__c

My theory is that Apple doesn’t really do R&D (Research and Development) in the traditional sense. Apple does R&P (Refine and Perfect). They rarely try to be first. They let the "courageous" tech companies push out the bleeding-edge tech first. Let Google, Anthropic and OpenAI deal with the hallucinations, the bad PR, and the user testing. Apple sits back, watches what works, gathers the feedback, and identifies the pain points. Once the technology is validated, they will swoop in with a highly polished, refined user experience and call it a day. That is likely the game plan for AI too. They aren't trying to invent the future. They are waiting to perfect it.

H0wlF0r0wl5

That's literally opposite of what they said.... Offshore is more expensive and slower to install but they do in fact operate more efficiently, with less overall risk profile in most cases due to the lack of wildfire risk with ocean based infrastructure, and the fact that we can literally build them larger out there. The name of the game with wind is size. The larger the turbine, the more power it generates AND the more efficient it is (reflected by higher capacity factor). If you've driven past turbines in any part of the US before, chances are you were seeing a turbine between 100 kW and 2 MW (2000 kW). It was probably a couple hundred feet tall with blades around 30-50 yards long. They have capacity factors from 20-40%, meaning over time they produce that percent of their baseplate rating in power due to intermittent nature of wind. To use the biggest and most progressed of these projects, CVOW, these turbines are 14.7 MW turbines, or 14,700 kW, and there are 176 of them for a nameplate output of 2.6 GW, which is a staggering amount of power. They are able to do this because they are huge - nearly a thousand feet tall from ocean floor to tip of blade when pointing up. The blades about the length of a football field with back to end zone to back of end zone. The capacity factor is huge 55%, meaning these things will be putting over 1.3 GW of power on the grid reliably over time, which is more than all but the largest 1-unit nuclear reactor-supplied steam plants. This would both a massive engineering challenge and an even bigger PR challenge to do onshore. Hence why they are offshore.

ShadowLiberal

IMO remote safely monitors are nothing but PR to convince people that they're safe. It's a horrible idea to let anyone remotely control a vehicle, and it opens up the possibility for so many scary cyber security issues if a hacker, or worse yet a terrorist gets remote control of someone's vehicle and decides to purposely crash it into something or someone.

OwlSlow1356

:)) plese tell us when they buy these, a PR column for the gullible investors it is not a sale :))

Wide_Neighborhood_49

Long puts on NNE. Fake aas company been talking about planning to file a building permit for two years, just bought some old ass patents and a PR team and went public.

Uzunzatu

ASTS just dropped a PR to say they've sent another satellite to launch. On a weekend as well. Ouch! Some short positions getting serious gapeage for Christmas.

CallMyAccountant

Id say its more around 35% a good restructure, 35% an okay restructure, 20% a bad restructure, and 10% if somehow shit hits the fan bankruptcy. Feb-march is when we get to see the Q4 2025 earnings, and that is when we can see if the PR deal was a game changer or not, and hopefully some events unfold as well.

Mission_Studio_6047

A few things that ARE real but noone ever makes a point to dig into it... 1. Since Covid, the shift to home office has dramatically risen, so a lot of people have shifted from the traditional lunch breaks so restaurant traffic is dramatically declining. So people are eating healthier... and smaller " quiick" portioning 2. Many CPG companies took advantage of Covid and increased prices to obscene levels because NOONE called them out... now these same CPG companies are feeling the backlash . PRICES MATTER! Most retailers do not have the infrastructure or R&D teams, thus most of their brands ARE made by the CPG companies...but virtually zero PR ie  advertising or marketing is done, so the retailer is making FAT margins with "agreements" to continue forward with legacy brands, most times that space is PAID FOR ie: slotting fees...and goes straight to the retailers bottom line. The market share is dominated by the largest retailers snd CPG companies... I'm patiently waiting for ALDI to make its way into TEXAS... chains here have been shafting consumers for decades

Correct_Proposal_409

Not sure I'm following you. I do believe they painted themselves into a corner in that they promised data by the end of the 4th quarter and also signed CDA's/embargos. But the GluSph biomarker was the big one all along, and they provided topline for that. You can find that this biomarker was [**pre-specified here**](https://gaintherapeutics.com/wp-content/uploads/2025/04/ADPD-2025-Phase-1b-Design.pdf). We also now know from the [**Roth report**](https://gaintherapeutics.wordpress.com/2025/12/19/gain-therapeuticsganx-roth-mkm-thought-on-phase-1b-data-raising-price-target-to-10/) that GluSph levels were reduced 75%-95% from baseline. That's a big deal. I think the company assumed that this alone would be big news and enough to lift the share price, but they obviously misread what this would mean for the average investor who has no idea what the implications of this biomarker means. In the PR, they did link the KOL event that had already been planned, and in which it states "The event will also review biomarker results from the Phase 1b clinical study of GT-02287, demonstrating disease modifying potential in Parkinson’s disease patients with or without a GBA1 mutation." In retrospect, they should have included this up top in the PR as one of the bullet points (instead of being relatively hidden in the link), something like "additional supporting data will be reviewed during our KOL event on Jan. 6th," To your statement on them raising-- they made it clear that they have enough cash to last through 2026, although this does not include phase 2. That's where partnership comes in, though. Lastly, yesterday's trading volume and price movement was very interesting. Nearly double the volume from the day before, which was the PR and big sell-off day, which was the biggest volume day in the company's history prior to yesterday. That's unusual. Usually it's the big sell-off day that is the high water mark for volume. Again, yesterday, where the share price recovered by finishing up 28%, the volume was nearly double from the day before (sell-off/news day). And there was also a record amount of after-marker volume. This tells me that there was some new buying coming in. Maybe life-science funds. And it would make sense. They are the ones who would understand the implications of what was shared in the PR from the day before.

ShittyUsernane1222

y'all realize that if a big law firm were to litigate 🥭 and force him to un-redact parts of the files, they would be having a massive PR victory and a lot of new clients due to increased reputation. It's a money printer waiting to be unleashed.

C130J_Darkstar

Hey! Sure- there have been meaningful developments around national plutonium inventories and fast reactor fuel. Oklo can use surplus plutonium as a bridge fuel for their initial scaling while their ~$1.7B recycling facility is built and brought online. That materially reduces near-term HALEU dependence and de-risks early deployment. It’s not only theoretical- they’ve already been testing the Pluto reactor and showing how this fuel cycle works in practice. These posts cover it well: * [LANL Pluto Testing PR](https://www.reddit.com/r/OKLOSTOCK/s/0bneNbAHFU) * [Pluto Video Explanation](https://www.reddit.com/r/OKLOSTOCK/s/7sbNWo07Gd) * [Upcoming Gov Plutonium Award](https://www.reddit.com/r/OKLOSTOCK/s/YTyIscVpjX) * [CNBC News Segment](https://www.reddit.com/r/OKLOSTOCK/s/6yUHKzZ9Ys)

Gambelero

No. I think Tilray will do what they did with beer. Make a big announcement about buying already operating companies in the states, and use the hype to dilute. Making profits there is a remote requirement. Simon wants to keep his gravy train going. Hyping to dilute is his game. California is the best candidate because there are thousands of struggling operators and the PR will be great. Remember when they bought beer brands from Imbev. The stock went way up even though they never had any hope significant profits from any of those operations. For an example of how it might work, look back at The Parent Company (now Gold Flora) which started with huge fanfare aiming to dominate the California market.

Tiaan

I was quite confused by Tilray's PR yesterday announcing Tilray Medical US. Particularly, I was very confused as to what the PR was actually saying this was. It described Tilray Medical US as a "strategic framework to advance its US medical cannabis operations." Are they going to be looking to buy up licenses in medical states? Are they going to be expanding into the hemp derived CBD for seniors space? Was this PR just a way to capitalize on the rescheduling EO? I don't really know I also don't think the Bondi final rule will take years but I'm not as optimistic to think it'll get done in weeks, especially given how long these administrative procedural tasks always seem to take. I'm thinking 3-6 months at least

Wide_Neighborhood_49

Why not throw away a couple billion for some positive PR. Its not like we can't just print more, right?

Correct_Proposal_409

As I understand it, there was one individual who shorted a million shares yesterday, taking advantage of the questions arising from the PR, which caused the panic and ensuing collapse. So, yes. But they can only do this short term. Buying opportunity.

Correct_Proposal_409

I definitely think the PR could have been better. So I think the management could do a better job with public announcements. But, again, these are scientists. They don't have marketing backgrounds. Not an excuse. My trust in the Gain leadership to develop a disease-modifying drug has not changed. They've been hitting homeruns every step of the way. So my confidence in them to that goal has only strengthened over time. And I think they might have learned a valuable lesson yesterday. Regarding the KOL event, it was already linked in the original PR. So the KOL was not just put together in response to the share price. They had planned this. But, you might be right that they put out s separate release with the goal to reiterate that the KOL event was planned and that they'll be discussing some further data.

ImaginationBroad2590

I appreciate the sentiment of your post, but it seems to me as if you're letting the company off the hook too easily for yesterday's gaffe. Do you have the same level of trust and confidence in leadership after yesterday? I'm not so sure the sell-off was over-reaction. The company promised one thing in its Q3 update and, along with the CEO's interview, fueled a steady run-up in anticipation of data. What was released was only a partial subset of what the company had promised. This fueled uncertainty and volatility in the marketplace that didn't need to happen. I think the second PR announcing the KOL event and this interview coming in the same day were last-minute decisions based on the trading and as good as an admission of just how much the company fumbled that PR. I agree that the underlying science is as good or better than what we thought two days ago, I honestly can't say that I trust the leadership team as much to adequately steer the company. Which will make me think twice about my position and whether I recommend this company to others. Have your thoughts on leadership changed at all from 2 days ago?

Nuka-Cide

Fair take on NXXT. Levels make sense, especially with PR risk hanging over it.

Flat_Pomegranate_164

Let me start by saying—this deal isn’t just a corporate merger. It’s a shot across the bow that two worlds we’ve long treated as separate media influence and frontier energy innovation are finally teaming up to build something that matters for real people. Think about it: TAE Technologies isn’t some fly-by-night startup tinkering with batteries in a garage. They’re deep in the trenches of fusion power—the “holy grail” of clean energy that could end our reliance on fossil fuels, slash emissions, and power generations without the downsides of traditional nuclear. And Trump Media? Love it or hate it, it’s a platform that cuts through the noise and reaches millions who are hungry for unfiltered, straight-talk takes on the issues shaping their lives. Putting these two together? That’s not just a $6B play. That’s a way to take a technology most folks only read about in sci-fi and shove it into the mainstream conversation. Fusion power won’t change the world if no one understands why it matters. Trump Media won’t move the needle long-term if it’s just spinning wheels on hot takes. But together? They can turn “fusion” from a buzzword into a kitchen-table topic—something your dad debates at the grill, your kid asks their science teacher about, and your neighbor actually cares about advocating for. Sure, there will be the cynics. The ones who say it’s just a PR stunt, or a cash grab, or a political play. Let ’em talk. Because here’s the thing: Big, world-altering ideas always start with people willing to take big, risky swings. Fusion power has been “10 years away” for 50 years—but maybe, just maybe, pairing it with a platform that can amplify its story is the push it needs to cross the finish line. Maybe this merger is how we stop waiting for clean energy to save us, and start building the future we want—together. At the end of the day, this isn’t about politics. It’s not about media ratings. It’s about two entities saying: “We’re tired of incremental change. We’re tired of the status quo. We’re going to bet big on a technology that could heal our planet—and use every tool we have to make sure it doesn’t get buried in red tape or apathy.” Here’s to hoping this isn’t just another headline. Here’s to hoping it’s the start of something that actually changes how we power our homes, our businesses, and our future. Let’s stop arguing about who’s behind it—and start cheering for what it could become.

HuckleberryOk4175

Main point: this sounds way more like a pitch deck pivot than a real AI infra business right now. When a tiny EV company suddenly talks “multi-vertical AI infrastructure” and sovereign data centers, I want receipts: signed contracts, MW of actual compute deployed, capex plan, and who’s funding it without nuking shareholders. Check the 10-Q for cash on hand, debt terms, and share count trend. If the only concrete thing is PR buzzwords (sovereign, drones, agriculture, workloads), it’s usually dilution bait. Also look at who the partners are and what they actually do. For real infra plays, you see boring stuff: colocation deals, power purchase agreements, and integration with things like Snowflake or service layers like Zapier; I’ve even seen folks use DreamFactory just to slap quick APIs on legacy data before calling it “AI.” So under $1 might be a trade, but I’d treat it as a lotto ticket, not a conviction long, until they show real revenue tied to this “AI” plan.

KeyIndependence7413

Main point: this sounds way more like a pitch deck pivot than a real AI infra business right now. When a tiny EV company suddenly talks “multi-vertical AI infrastructure” and sovereign data centers, I want receipts: signed contracts, MW of actual compute deployed, capex plan, and who’s funding it without nuking shareholders. Check the 10-Q for cash on hand, debt terms, and share count trend. If the only concrete thing is PR buzzwords (sovereign, drones, agriculture, workloads), it’s usually dilution bait. Also look at who the partners are and what they actually do. For real infra plays, you see boring stuff: colocation deals, power purchase agreements, and integration with things like Snowflake or service layers like Zapier; I’ve even seen folks use DreamFactory just to slap quick APIs on legacy data before calling it “AI.” So under $1 might be a trade, but I’d treat it as a lotto ticket, not a conviction long, until they show real revenue tied to this “AI” plan.

newyolker

China should take all the illegals the US are deporting and let them do tiktok videos of their new life in China , this would be such a good PR move

noobstockinvestor

Tilray put a PR that they are entering the US medical market

WollopDollop

CWEB is a scam, stay away. It would be on bankruptcy without their pumpy PR

MediumSinger8088

Sorry for a late post, I actually had other stuff to do today -I post also - though I'm nuanced and express both sides of the argument as I see it and warned folks not to count all the chickens before they hatched. I am cautiously optimistic on this one in the medium-long term, but getting a drug to clinic takes time, big pharma will want to see some statistical significance before a huge commitment. IMO partnership in 2026 is very likely, to get through placebo-controlled trials. I admit the magnitude of the drop today was unexpected. There is no logic here; only chaotic dynamics. Narratives will be written later espousing whatever supposed reasons but nobody did a reasoned analysis in a few minutes between PR release and market open. There was a knee-jerk reaction that took out some speculative froth and it fed upon itself thanks to computer algos. Granted, if you are killed by chaos you're just as dead. I would have preferred if the company hadn't at least inadvertently telegraphed stronger data - like perhaps the rest of the initial cohort demonstrating broader biomarker results or continued trends on the MDS-UPDRS. Would that have mattered? Maybe, maybe not. In truth the 90 day study only finished in December and there doesn't seem enough time to process the samples, share data with FDA committees and senior investors etc then rush out a full publication in the press (Science by PR - ick). It makes more sense to dribble out the most important foundational finding then wait for a major conference in 3 months to talk about some of the rest. The "chatter" is the appropriate level in the medical field. I liken it to maybe the Tecfidera case in MS a couple of decades back. Physicians and scientistsa are very conservative people with busy lives who will pay attention when/if Phase2/3 trial results turn positive or there is FDA approval. They won't be feeding their patients hope too early. In an era when even multi-billion market cap stocks swing 10% daily on .. whatever... this isn't all that crazy.

medicated_in_PHL

No, people are just smart and educated, paid attention when this happened 3 years ago, and understand that this is just another non-serious smoke and mirrors PR stunt to take attention away from tomorrow’s release of the Epstein files. - The President has no authority to reschedule drugs. - Congress has the authority but will not act on it. - The DEA has intentionally borked the rescheduling process for the last 3 years to make sure that it never sees the light of day. - Part of that borking process was keeping key stakeholders out of the rescheduling process which led to multiple lawsuits that continue to tie up the process that DEA intentionally let languish. People are smarter than you think they are, and they were paying attention to the process when you weren’t. That’s why they aren’t “taking a win”.

Correct_Proposal_409

Very unfortunate market reaction to positive news which goes a long ways towards confirming that the drug is working. The PR was to conservative, and they are holding back additional data (possibly due to CDA with a pharma partner, or the are holding data for the KOL event and the AD/PD conference, not sure). Regarding the KOL event, it sounds like they will be reviewing additional data: “The event will also review biomarker results from the Phase 1b clinical study of GT-02287, demonstrating disease modifying potential in Parkinson’s disease patients with or without a GBA1 mutation.” I just wish they had put that as one of the top bullet points for the PR. I’m holding for buyout/partnership, which I think is more likely now. BTW, the BTIG analyst just came out with this note, and he agrees: “Readout Suggests GT-02287 is Activating GCase in the CNS. Additional Steps to Confirm it a PD Drug, but the Gain Approach Works. WHAT YOU SHOULD KNOW: We see the findings today serving as definitive evidence supporting GT-02287's ability to activate GCase in the brain. As a result, we see validation for the Gain approach and increased likelihood others will agree and look to partner other novel applications where allosteric modulation of enzyme deficiencies might benefit patients. The readout today measured the levels of GCase substrate, glucosylsphingosine (GluSph) in the CSF. The observed GluSph reductions in every patient that had elevated levels of this GCase substrate at trial start make it clear: GT-02287 increases the activity of its target enzyme. After 90 days of GT-02287 treatment, all individuals with elevated CSF GluSph experienced significant decreases.”

TherealCarbunc

also to add to the above: # The "Heavyweights" at the Table (Restructuring) This isn't just a generic debt talk; the world’s most powerful restructuring firms are in a room deciding the fate of the company. **Representing NFE:** **Houlihan Lokey** (the #1 global restructuring advisor). They specialize in "Liability Management," which is a fancy way of saying they find ways to save the company and the equity without a total wipeout. **Representing the Lenders:** **FTI Consulting**, alongside heavy-hitting law firms **Akin Gump** and **Paul Weiss**. **The "UK Scheme":** Management is reportedly exploring a **UK Scheme of Arrangement**. Unlike a US Chapter 11, this is often faster, more surgical, and can allow the company to restructure its debt while keeping its massive assets (like the PR contract) untouched. **Why it Triggers a Squeeze (The "Survival" Rally)** Short sellers are currently betting on a **$0.00** outcome. A U.K. Scheme is a court-sanctioned deal that allows NFE to keep operating. * **Removing the Zero:** The moment a Scheme is sanctioned, the "Bankruptcy" thesis dies. Shorts who are paying **98% interest** to wait for a collapse will realize they are trapped in a solvent company. * **The Forced Cover:** If the stock price jumps on the news of a successful restructuring, shorts will be forced to buy back **64 million shares** into a rising market to limit their losses. # 2. The Impact on Current Shareholders (Dilution vs. Value) A U.K. Scheme usually includes a **Debt-for-Equity Swap**. This means some of NFE's $9.3B debt is deleted in exchange for new shares. * **The Bad (Dilution):** Your percentage of the company gets smaller because there are more shares in existence. * **The Good (Enterprise Value):** While you own a "smaller slice," the **size of the pie** often grows significantly. A company with $4B in debt is worth exponentially more to the market than a company with $9B in debt. * **Contract Protection:** Unlike a U.S. Chapter 11, the U.K. Scheme is designed to be **"contract-neutral."** This means NFE's crown jewels—the **$3.2B Puerto Rico contract** and the **Brazil terminals**—remain intact and operational, protecting the underlying value of the business. # 3. Why Houlihan Lokey matters here NFE hired **Houlihan Lokey** specifically because they are the masters of the "Liability Management Exercise" (LME). * Their goal is almost always to **avoid a wipeout.** * They often structure deals where existing shareholders keep enough equity to benefit from a "recovery rally." If they can negotiate a deal where debt is pushed back (matures later) rather than converted to shares immediately, dilution is minimized, and the squeeze potential maximized.

Correct_Proposal_409

I'm down a lot. Tough day. Honestly, if I didn't already own so much, I'd be buying here. Stepping back and setting emotions aside, the biomarker data from today only further validates the drug. I think the PR was unfortunately a little too light on data and perhaps more layman-friendly language regarding implications of the one (very important) biomarker that they featured in the PR. I believe there will be an interview soon (maybe tomorrow) and the KOL even on the 6th where we'll get some more information. I think there are positive reasons they help some info back, for example: CNA with potential partners, regulatory risk (in speaking on sense of smell in the PR), AD/PD in March which requires any presentations to be new data (so they are holding for that), waiting for more KOL analysis. Anyway, I'm holding. This drug is worth much more than current SP indicates, IMO.

Competitive-Ant2876

So the EO was a nothing burger, has expected lmao. Clearly a PR stunt. Nothing changes at all, Glad I sold. Sector is so easy to trade.

sandygws

Agreed. They need to fire their entire PR team and start from scratch.

Correct_Proposal_409

It think the way the PR is organized, they are holding back some data for the KOL event. That they are able to reduce GluSph to near healthy levels consistently in those patients with elevated levels is really big. The scientific community will be excited by this. The investor market will take time to digest this. I think institutional buying might start ramping up since this goes a long way towards derisking the drug, but that probably doesn't happen immediately.

East-Friend1357

Read a few hours back on another subreddit that someone within his administration leaked that it was just a PR stunt

SignificanceLate7002

Someone leaked that it's just some fluff PR bullshit.

johndsmits

hate the ORCL drop today... Between Paramount and AI DC debt shows how bad Oracle at PR/marketing and strat planning. They act like a 5 person SPAC.

JacksonBrooks63

if they just slap “AI-powered grid orchestration” into the PR it’s a 3x easy

Strydor

To give people a more informed decision, $SLS predicts the 80th event for GPS will happen this month or at any time soon. This starts a countdown timer for top line results. However, the one thing that isn't mentioned here is that they have [inducement warrants for up to 22,363,714 shares of Common Stock with an exercise price of $2.00 per share that was announce at end October.](https://ir.sellaslifesciences.com/news/News-Details/2025/SELLAS-Life-Sciences-Group-Announces-Exercise-of-Existing-Warrants-Held-by-a-Current-Institutional-Investor-for-31-Million-in-Gross-Proceeds/default.aspx) Your upside is limited at current price until the PR happens.

makeyousaywhut

I just don’t understand the disrespect at all. It would’ve cost him nothing to say nothing. It would’ve even looked good on him to express heartfelt condolences and show a little bit of humanity while commenting on a really horrific and public situation. Furthermore Rob Reiner had incredibly few enemies, which is more than most public figures can say, so he’s a weird target. But he chose to disrespect the dead, and I truly don’t understand the PR decision making process. Does he really just have unfiltered access to his twitter, or was this a team effort? The whole thing is just sad and confusing.

devolution_king

Google put together a pretty impressive technical paper on the matter - included in the post. I don't see how their interest in the subject could be reduced to a PR stunt. They just don't need it. If it was only SpaceX and NVIDIA talking about it, I would be a lot more skeptical of the concept being advanced to prop up share prices - but its everyone. Amazon (AWS in orbit and Amazon Leo) and Microsoft (project Azure space) also in the game.

LBCkook

You keep saying “when they figure it out”. Here is what is going to happen. Waymo is going to continue to take market share, while Tesla spends years still trying to rely on their 8 cameras. They will get bad PR after accidents occur because cameras are prone to issues (sun glares, misreading humans walking, black ice, etc.) Waymo is so far ahead of them that it’s not even funny, and consumers aren’t going to play favorites with Tesla. Waymo’s are all over LA right now. Tesla FSD isn’t. As for their humanoid robot. This is 2013 era Boston dynamics tech. It isn’t new in any way. What do you think these things are suddenly going to do for us? Wash our cars? You think a robot is going to run to the grocery for us, pick everything out, come back and cook us dinner in the next 5 years? You’re absolutely delusional if you think that sort of tech is at a scale where it can happen, let alone that it would be economically viable for public purchase. It’s just bullshit, and it will continue to be bullshit, and the fan boys couldn’t explain the technology in the competitive landscape if they tried. They couldn’t tell you the difference between Waymo and Tesla, because they are buying a house of cards

tedrivers

If you don't know about Gatekeeper its worth doing some research on. [Recent PR](https://www.gatekeeper-systems.com/investors/press-releases/)

overhill-behind

Just so you know, bankruptcy would actually help PR not NFE. Because it probably would restructure everything and focus only on the revenue making areas which is only PR. That would mean all the non revenue assets which are substantial that have nothing to do with PR would be wiped out like Brazil. PR doesn’t care if NFE has to do a chap11, they don’t lose anything.

GotWaresIfYouGotCoin

Pretty much. A missed payment is gonna flush it. Making it will be great, an extension is half kind of bullish I think, even though a bad sign and making things take longer, with the PR contract should make money. Getting the FEMA money is just a big boost that can't really be predicted, that comes in at the right time if it does.

WutangClangz

when did you buy roblox calls? $118 calls aren't unreasonable, but I don't understand the time-frame. The entire market is looking to understand how much Roblox doubles down into their investments to keep children safe, because everyone knows its a bottomless pit, and that by acknowledging it, Roblox essentially has to pull a "PayPal" with Captcha and kill the pedos in 1 swoop. Yeah there's a bunch of lawsuits ongoing but those get settled 99% of the time. The biggest risk to Roblox is how to detach itself from it's CP-magnet, and if you ask me, the easiest way to do it was to throw the ball in someone's else court. Mention how CP's do most of the illegal stuff on other social platforms like Discord or more maliciously, Facebook's platforms and that to combat it, you need to form a coalition of sorts with all social media platforms. Essentially becoming the champion, and getting the PR, while putting the ball in other company's courts who have historically ignored this consideration.

SangerGRBY

Elon just needs to work on PR. If TSLA becomes retails baby, this shit is gna pump to 1k overnight. Elon is way too unlikeable.

OdistCo

What optics. This dude needs a PR Firm pronto. The backdrop, the drip, the B roll, all of it. Wait until stockholders grasp Chapter 56 and discover what the government thinks is “Arms Length”. Dude will be on here trashing descheduling as “destroying the legal industry”. GTFO.

GeoLogic23

Democrats are the only reason there is anything for Trump to direct the DEA to finalize... Trump would just be directing them to sign off on the work done by Biden's HHS because of Biden's executive order. Trump again doing no work, and taking the credit. With comments like yours helping his PR. We have more than just Schedule 3 we need. We need Congress to do several things. Ignoring who has gotten us to where we are will just set us up to be taken advantage of in the future. Congressional Republicans have been openly hostile to high dose cannabis products.

Davidinlbc

He needs the positive PR now. I think he'll use it!

kaapooj

https://markets.ft.com/data/announce/detail?dockey=600-202512151140PR_NEWS_USPRX____PH47634-1

moorhound

"I have degenerative eye disease and have been dealing with retinal tears for years, and after using VIZZ (but not on the day of the incident) I got a retinal tear" 🙃 This will eventually blow over, but it's definitely a kick in the buts to momentum. LENZ will probably be doing a bunch of PR to clear all of this up before SK approval stuff.

ShotBandicoot7

TSLA: every micro-nano-mini-dip gets immediately bought back up. Crazy. Pump the stock 5 times on the same PR stunt.

ShotBandicoot7

TSLA and CVNA. Meme stock day fueled by TSLA PR.

SubstantialMaize2564

Shocker! Both [$NVVE](https://stocktwits.com/symbol/NVVE) & [$MIST](https://stocktwits.com/symbol/MIST) couldn't hold their gains, meanwhile I'm loaded in & loving every development that comes for Capstone, like their PR from this morning ["Capstone’s 2026 Outlook Reaffirms $100M Run-Rate Target and Outlines Path to 10% EBITDA Margins."](https://capstoneholdingcorp.com/capstones-2026-outlook-reaffirms-100m-run-rate-target-and-outlines-path-to-10-ebitda-margins/) It's only a matter of time before the rotation into small CAPS occurs & when it does, hold on. The re-rate will be \*marvelous\*...

RaZE___SoViEt

PM Watchlist: **$MIST** : 8pm Friday FDA Approval T1 Halted : https://www.reddit.com/r/pennystocks/s/lVN6fiq9iL **$ASBP** : Compliance extension (20% AH) : https://finviz.com/news/253256/aspire-biopharma-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements **$PFSA** : catalyst Dec 11-13, Watching for PR : https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025 **$YCBD** Weed plays still active. **$OCG** : still in with half at 0.223 from discord call out, thanks u/SadisticBean27 **$NVNI** : Reddit hype, 1.3M Float 12% Shorted, needs volume : **Dec-10** CEO acquire 1.5M Shares at 4$ https://finviz.com/news/246689/nuvini-founder-and-ceo-pierre-schurmann-commits-6-million-at-significant-premium-to-market-price

Due-Papaya-6217

PFSA - According to a Head of vascular surgery on LinkedIn, following the Paris conference this weekend he referred to Profusa’s product as “extremely promising” Up 12% overnight - now we wait for the official PR.

Vonauda

Always has been. This is what happens when you ignore PR people unlike the liked billionaires/companies.

jcpham

senile old man poses in front of staged PR stunt photo

RaZE___SoViEt

PM Watchlist: **$MIST** : 8pm Friday FDA Approval T1 Halted : https://www.reddit.com/r/pennystocks/s/lVN6fiq9iL **$ASBP** : Compliance extension (20% AH) : https://finviz.com/news/253256/aspire-biopharma-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements **$PFSA** : catalyst Dec 11-13, Watching for PR : https://finviz.com/news/237253/profusa-to-present-late-breaking-us-based-clinical-trial-update-at-paris-vascular-insights-2025 **$YCBD** Weed plays still active. **$OCG** : still in with half at 0.223 from discord call out, thanks u/SadisticBean27 **$NVNI** : Reddit hype, 1.3M Float 12% Shorted, needs volume : **Dec-10** CEO acquire 1.5M Shares at 4$ https://finviz.com/news/246689/nuvini-founder-and-ceo-pierre-schurmann-commits-6-million-at-significant-premium-to-market-price

SubstantialMaize2564

Got in at the wrong time? I rode ~200k+ shares from $.80 to over $2 so I’d say I got *out* at the right time. I instantly saw through their BS crypto PR (excess cash? What excess cash?) & was fearful when others were greedy. I may just post that one every day on here because it’s so important tbh. Be fearful when others are greedy… Good luck!

Imaginary_Shoulder19

QCLS cap-math sanity check. Position: tiny starter \~4.8. Why I care: advisor deal signed; tiny share count (\~4.17M); but big registered-for-resale supply. Quick math: every $10M market cap ≈ \~$2.40/share on \~4.17M SO. • If they land a named, paid pilot + credible third-party benchmark → $40–$80M cap (\~$9.5–$19/share) pre new issuance. • If it’s just PR/no customers → likely tracks book/cash (\~$5–$8). • If resale/dilution hits hard → $2–$4. Question: how would you price a paid pilot with third-party validation? Does the resale stack cap upside until revenue/benchmarks?

Tufannnn

The PR regarding the US DoD selection for the golden dome https://investors.momentus.space/news-releases/news-release-details/momentus-selected-us-space-force-shield-contract-vehicle

Relative-Wealth-3335

This is AI bubble companies (SoftBank, Oracle, Nvidia, and OpenAI): big budget announcements, overpromising, using creative math, and having CEOs spend too much time on PR to pump stocks and sustain circular spending, instead of focusing on execution and real technology improvements. AI-bubble companies - LOUD and EXPENSIVE.

n3onfx

There's a reason nobody buys them outside of the occasional PR stunt.

SignificanceLate7002

AMCI - AMC Robotics Corp De-SPAC squeeze play. Previously ATMV. Merger closed Tuesday and new ticker name effective Wednesday. Low float at 1.44 million. CTB is 700%. Pre-merger price was $14. This one could be explosive Monday. The merger close and new ticker name happened rather quickly with very little PR. Some brokers failed to update until Friday so little attention was paid to this one. Shorts used this to their advantage on Friday and drove rather price down about over %60 to $2.70 on low volume. About 350k volume during market hours. AH things turned around quickly and probably caught shorts by surprise gaining back most of the losses and closing out at $4.50 with over 1 million in trades during the AH. This is a US based robotics company that has been in the warehouse automation sector for a long time with a new autonomous robot security patrol line. Here's a link to their website to check them out. https://www.amcx.ai/

Karajoannes

Maybe it is a naive idea, but what about threatening you will involve the press if they do not unfreeze by a certain date? The PR damage, especially if more people come out with similar issues, might be worth more to them than the legal repercussions. I have done it against an institution in the past and, overnight, they magically solved an issue that had been dragged for months.

SignificanceLate7002

Looks like it. At least until we get a PR or something. I like the look of the company but they need to do something to get people interested. Maybe we'll get a big announcement next week.

The_Insider_Edge

“Herbal Dispatch holds a unique position among Canadian public cannabis companies with the sector's longest growth runway. While competitors have already saturated all three core growth vectors — national provincial listings (9-10 provinces, 100-300+ SKUs), mature medical channels (30-60% of revenue), and recurring exports to established clients — Herbal Dispatch has not. The Company stands alone in its ability to simultaneously double medical sales and provincial footprint/SKUs while tripling exports, opportunities its public peers exhausted years ago. This convergence of untapped channels positions Herbal Dispatch for the sharpest revenue acceleration in the entire public cannabis sector over the next 24-36 months.” From the most recent PR

graps2

If you believe that “China really wants h200’s. Omg you guys we are just killing it” story planted by NVDA PR you should go be checked for Down Syndrome 

stevenryl866

Thx for sharing this. PR should come release soon and it will pop. Multiple FDA designation and not including the current new one.

yea-uhuh

Re-scheduling will not be a 2025 headline. Whitehouse finalizing a PR strategy, only because of imminent SCOTUS meeting headline. EO language certainly isnt imminent yet. This looks more like a pre-christmas organized pump & dump, a quick Friday spike, volatile correction to follow next week(s). Prohibitionist leaked a rumor of the conversation on X, early morning, before a huge run-up as the rumor blew up elsewhere (WaPo). Great cover for early buy-ins today

Dragonasaur

They're the same price, but Alo just has excellent marketing where Lulu doesn't, since they rely on word of mouth and a good reputation for good quality Alo's reputation for quality is also in the dumps, but the Kardashians have advertised for Alo Lulu also keeps making bad PR moves (no surprise, look at the origin of the name), like complaining about lower quality Costco dupes

Glass_Bad6980

After digging it a little bit, I think there might be a chance for a PR if the meeting is very positive and clear. Very clear green light to BLA submission is a material information, they might be obligated to share it according to SEC rules. But it has to be very clear during the meeting. It’s a weird case because seems like it is very rare where the exact date is publicly released 1 month before the meeting.

Glass_Bad6980

Thanks, but couldn’t find the meeting month. Also 30 days for minutes is a deadline, doesn’t have to be always 30 days. Maybe I should say, it’s rare to have a PR immediately after the meeting, few weeks later might happen. It happened in uniQure recently. Meeting was so bad, so they announced it maybe a week later without minutes. I guess for a PR immediately after the meeting, verbal discussion should be very positive and clear. Also the type release you sent can cause relatively less volatility. We’re talking about a BLA submission this time, might cause more legal problem if there is a mismatch between PR and minutes. I hope they release a PR tbh, because they created this hype by sharing the exact date etc.

Glass_Bad6980

Can you show me Moonlake’s previous announcements before minutes, maybe I missed it. This is an example recent PR from a different company for instance: https://ir.biorestorative.com/news-events/press-releases/detail/230/biorestorative-granted-type-b-meeting-with-fda-to-discuss-accelerated-bla-approval-pathway-for-brtx-100-in-chronic-lumbar-disc-disease . Generally the meeting time is a little vague unlike Moonlake’s case. So maybe this is different. This is one of the very few examples I found. Actually, they did a PR after few days, it’s from 2022 though : https://ir.iovance.com/news-releases/news-release-details/iovance-biotherapeutics-announces-regulatory-and-clinical . I would appreciate if you send some examples of immediate PR after the meeting with clean message. I hope they do though, I’m also holding 19 December options.

NoRhubarb2277

What's the likelihood RZLT announces a dilution for fundraising after their failed phase 3? Anyone any thoughts? They like to drop that PR at 4PM typically.

KRAFT_MAY0

Company’s behavior is very reminiscent of other companies with PR to float them through any RS risk. Social sentiment has turned bullish and they’ve been drip feeding PR all week. Still risk Ofcourse, but asymmetrical reward of my intuition is correct. I believe their deadline is the 18th (not positive)

Glass_Bad6980

Generally the biotech standard is waiting until the minutes arrive, and release a PR. This is a complicated situation though, they specifically announce the meeting date and created a catalyst date. The problem with a bullish PR right after the meeting is, there is no legally binding proof about the verbal discussion. So if something different shows up in the minutes, MLTX might be sued again. I also have some December 19 options, but don’t really expect an explicit PR right after the meeting. It’s kind of a gamble at this point. I think they’ll get a green light for BLA, but they might not release it until January, or use vague PR after the meeting. If you check their Q3, they specifically say minutes will arrive in 30 days after the meeting. They already pointed out that.

spinwizard69

Yes and I've seen last minute denials from the FDA that has really screwed up a plans. When there are actual approvals then we can put more value on those PR's and CEO comments.

Firm-Bottle2064

RIME PR drop contract expansion https://preview.redd.it/a70mj1bo6l6g1.png?width=388&format=png&auto=webp&s=7367d0251b35a154b6ccbc1bc4747237a8e8476f

NoahReed14

Yep NXXT just dropped PR [https://www.globenewswire.com/news-release/2025/12/11/3203960/0/en/NextNRG-Signs-28-Year-Microgrid-Power-Purchase-Agreement-with-Topanga-Terrace-Further-Advancing-Its-Expansion-into-Healthcare-Energy-Infrastructure.html](https://www.globenewswire.com/news-release/2025/12/11/3203960/0/en/NextNRG-Signs-28-Year-Microgrid-Power-Purchase-Agreement-with-Topanga-Terrace-Further-Advancing-Its-Expansion-into-Healthcare-Energy-Infrastructure.html)

kaapooj

need some scrappy PR pieces about Zuck's day to day hands-on AI leadership

Connect-Funny-4583

To me those are just PR talks. He can't talk shit about China and expect to be welcomed there. China still don't have TSMC level manufacturing and those high-end stuffs.

skilliard7

This subreddit seems to take GOOG's PR articles as non biased evidence just fine. Plenty of third party benchmarks too

havok4118

Lol well posting a PR article as non biased evidence is certainly convincing

gamjatang111

just super ironic that he acknowledges people are getting screwed yet does the opposite. At least give a PR answer

ImaginationBroad2590

Wait till the factory in New Hampshire is completed and gets PR’d, should be in the next couple months. This stock has legs!

SignificanceLate7002

Brought this one up a couple times the last few days while it was still ATMV and got downvoted. It's an American Robotics company that is just listed under new ticker AMCI this morning after merger closed late yesterday. It should move quickly once news gets out. Merger finished rather quietly with little PR.

DOE_ZELF_NORMAAL

I get the analogy, but it kinda falls apart because Tesla isn’t lifting weights here, they’re rewriting the rulebook on how autonomy even works. Waymo/Cruise-style demos are basically lifting a very specific 10-pound dumbbell: mapped route, limited conditions, curated ODD. Tesla’s trying to build the general-purpose strength to lift any weight in any gym. Different sport entirely. And yeah, in the real world most companies show incremental progress. Totally fair point. But Tesla’s approach isn’t incremental by design, they aren’t building the “highway only mode,” then the “city only mode,” then the “left turns after 3pm” mode. They’re training one brain to handle the whole thing. That’s why a single demo doesn’t tell you much about whether that brain is actually generalizing or just memorizing a loop. If Tesla trotted out a single autonomous ride tomorrow, people would (rightly) say: “Cool, now do it at night. Now in the rain. Now with construction. Now in Boston. Now during a solar eclipse.” A one-off demo doesn’t validate the thing they’re trying to build. None of this means Tesla is guaranteed to nail it, obviously. But pretending a flashy PR run is some magic indicator of technological maturity is rough logic. Waymo did their demos a decade ago and still can’t scale outside tightly groomed ODDs. Cruise aced demos then faceplanted in real deployment. If Tesla’s gamble pays off, it’ll look like “nothing nothing nothing… BAM, widespread rollout.” If it doesn’t, sure, they’ll have overreached. But holding them to the demo standard of systems built on a completely different architecture is just comparing apples to orbital rockets.

DOE_ZELF_NORMAAL

I mean, sure, a flashy “Elon in the backseat, pick a random destination” demo would look great. No argument there. It would nuke half the skepticism overnight. But that’s kinda the point: Tesla doesn’t want to do a one-off stunt that works because 300 engineers pre-scouted every pothole and construction cone along the route. Waymo and Cruise had to do that stuff because their tech only works inside carefully managed bubbles. Tesla’s trying to avoid building a system that only shines when conditions are curated. And yeah, the fact they still use safety drivers is a sign the system isn’t at that level yet, nobody’s denying that. But “they haven’t done a demo ride” isn’t proof of failure, it’s just a reflection of the fact that Tesla’s bar for what counts as meaningful autonomy is way higher than a PR loop. When they finally let a passenger ride with no human in the front, it’s gonna have to work basically anywhere, not just in a painted box in Phoenix. That’s the difference: Tesla doesn’t want to show a trick, they want to show a capability. Risky strategy? Absolutely. But it’s not the same thing as “they can’t even do a demo,” it’s that they don’t want to ship a show pony when the goal is a workhorse.

Quiet_Reputation_128

$MIGI some buyers today after PR for a Thursday presentation. 900k float

Future-Use-7534

Nah. My 2100% returns in PR (mid cap oil co) since 2020 have been life changing. Research and invest in good companies and swing trade some momentum stocks (good companies only for me, no meme BS). Be disciplined and cut the losers (7%-9% is my rule of thumb). No stress here.

DOE_ZELF_NORMAAL

The “splashy demo” thing is kinda a weird bar because Tesla doesn’t need one to sell cars. Waymo, Cruise, Zoox, etc. all needed PR loops because their business model is literally robotaxi demos. Tesla’s is: ship software to millions of cars and improve it in the wild. And honestly, a curated VIP loop doesn’t prove anything for Tesla’s approach. Their whole pitch is generalization, not “look how clean this one route is.” If they did a demo tomorrow, people would immediately say “okay but try it in a construction zone in Boston at night in the rain” because that’s the standard they’ve set for themselves. The “delay” isn’t because they can’t do a hand-picked loop. It’s because a single choreographed ride doesn’t match the goal they’re selling or move the needle. If they ever do a big demo, it’ll be because the thing works broadly enough that a one-off showcase isn’t needed, not because they finally managed a Disneyland tour route. You can absolutely argue Tesla overpromised timing, fair criticism. But “they haven’t done a PR stunt so they must not be able to drive a loop” is just not the flex people think it is.